$Unitedhealth(UNH.US)Restating the 2025 EPS forecast at $16, which aligns with the current share price of $320, resulting in a P/E ratio of 20.
I believe this is still quite stable—most of the major risks have been addressed, and the company’s operations have returned to normal. After all, a P/E ratio of 20 for an INDUSTRY LEADER is reasonable and not overpriced.
If it weren’t for the recent crisis, the EXPECTED EPS would likely have been around $30. Now that the stock price has bottomed out, if the EPS gradually returns to a normal level, the stock price should follow suit and rise accordingly.
Alright then. Let time do its work.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
